secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acrivon Therapeutics, Inc. (ACRV)
CIK:        0001781174
Form:       8-K
Filed at:   2025-06-13T23:59:59+00:00
Accession:  0000950170-25-086246
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Acrivon stockholders elect three Class III directors and ratify PwC as auditor
------------------------------------------------------------------------------

- Quorum of 29,659,010 shares (94.59%) present at 2025 annual meeting on June 13.
- Peter Blume-Jensen (26,612,623 for), Derek DiRocco (24,606,548), Santhosh Palani (26,246,868) elected as Class III directors.
- Ratification of PricewaterhouseCoopers LLP as auditor for FY2025: 29,653,924 for, 3,673 against, 1,413 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1781174/000095017025086246/0000950170-25-086246-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1781174/000095017025086246/acrv-20250613.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-086246

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer